Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00377546 · ClinicalTrials.gov registry record · Phase 4

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

A Phase 4 study, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase

NCT00377546 is a Phase 4 study that has completed, run by Innovative Medical.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00377546, a Phase 4 study, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase

Study Summary

To compare the penetration of three different NSAIDs.

Interventions

  • DRUG Nepafenac
  • DRUG Ketorolac LS, Bromfenac

Trial Details

FieldValue
Phase Phase 4

Sponsor

Innovative Medical

44 total trials

What the Registry Record Tells You About NCT00377546

The ClinicalTrials.gov registry entry for NCT00377546 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nepafenac is the first listed.

NCT00377546 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00377546 about?

NCT00377546 is a clinical study titled "Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%". To compare the penetration of three different NSAIDs.

What is the current status of trial NCT00377546?

This trial is currently completed. It is a Phase 4 study.

What interventions are being tested in trial NCT00377546?

The interventions under investigation include: Nepafenac (DRUG), Ketorolac LS, Bromfenac (DRUG).

Who is sponsoring clinical trial NCT00377546?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.